New Research: Key Drivers of Growth

NEW YORK, Feb. 13, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of WPX Energy, Inc. (NYSE: WPX ), ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ), Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX ), MobileIron, Inc. (NASDAQ: MOBL ), Arrow Electronics, Inc. (NYSE: ARW ), and Abeona Therapeutics Inc. (NASDAQ: ABEO ), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

WPX DOWNLOAD: http://MarketSourceResearch.com/register/?so=WPX ACAD DOWNLOAD: http://MarketSourceResearch.com/register/?so=ACAD LXRX DOWNLOAD: http://MarketSourceResearch.com/register/?so=LXRX MOBL DOWNLOAD: http://MarketSourceResearch.com/register/?so=MOBL ARW DOWNLOAD: http://MarketSourceResearch.com/register/?so=ARW ABEO DOWNLOAD: http://MarketSourceResearch.com/register/?so=ABEO

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Market Source Research, available for free download at the links above, examine WPX Energy, Inc. (NYSE: WPX ), ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ), Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX ), MobileIron, Inc. (NASDAQ: MOBL ), Arrow Electronics, Inc. (NYSE: ARW ), and Abeona Therapeutics Inc. (NASDAQ: ABEO ) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed February 11th, 2019. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

WPX ENERGY, INC. (WPX) REPORT OVERVIEW

WPX Energy's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, WPX Energy reported revenue of $484.00MM vs $145.00MM (up 233.79%) and analysts estimated basic earnings per share -$0.01 vs -$0.38. For the twelve months ended December 31st, 2017 vs December 31st, 2016, WPX Energy reported revenue of $1,336.00MM vs $693.00MM (up 92.78%) and analysts estimated basic earnings per share -$0.08 vs -$2.05. Analysts expect earnings to be released on February 20th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.02. The estimated EPS forecast for the next fiscal year is $0.26 and is expected to report on February 20th, 2019.

To read the full WPX Energy, Inc. (WPX) report, download it here: http://MarketSourceResearch.com/register/?so=WPX

-----------------------------------------

ACADIA PHARMACEUTICALS INC. (ACAD) REPORT OVERVIEW

ACADIA Pharmaceuticals' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, ACADIA Pharmaceuticals reported revenue of $58.31MM vs $35.58MM (up 63.88%) and analysts estimated basic earnings per share -$0.50 vs -$0.53. For the twelve months ended December 31st, 2017 vs December 31st, 2016, ACADIA Pharmaceuticals reported revenue of $124.90MM vs $17.33MM (up 620.68%) and analysts estimated basic earnings per share -$2.36 vs -$2.34. Analysts expect earnings to be released on February 26th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was -$0.55. The estimated EPS forecast for the next fiscal year is -$1.74 and is expected to report on February 26th, 2019.

To read the full ACADIA Pharmaceuticals Inc. (ACAD) report, download it here: http://MarketSourceResearch.com/register/?so=ACAD

-----------------------------------------

LEXICON PHARMACEUTICALS, INC. (LXRX) REPORT OVERVIEW

Lexicon Pharmaceuticals' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Lexicon Pharmaceuticals reported revenue of $6.86MM vs $26.94MM (down 74.55%) and analysts estimated basic earnings per share -$0.26 vs -$0.29. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Lexicon Pharmaceuticals reported revenue of $90.34MM vs $83.34MM (up 8.40%) and analysts estimated basic earnings per share -$1.23 vs -$1.36. Analysts expect earnings to be released on February 28th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was -$0.31. The estimated EPS forecast for the next fiscal year is -$0.28 and is expected to report on February 28th, 2019.

To read the full Lexicon Pharmaceuticals, Inc. (LXRX) report, download it here: http://MarketSourceResearch.com/register/?so=LXRX

-----------------------------------------

MOBILEIRON, INC. (MOBL) REPORT OVERVIEW

MobileIron's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, MobileIron reported revenue of $49.25MM vs $45.51MM (up 8.23%) and basic earnings per share -$0.07 vs -$0.15. For the twelve months ended December 31st, 2017 vs December 31st, 2016, MobileIron reported revenue of $176.49MM vs $163.93MM (up 7.67%) and analysts estimated basic earnings per share -$0.60 vs -$0.78. Analysts expect earnings to be released on April 25th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$0.17.

To read the full MobileIron, Inc. (MOBL) report, download it here: http://MarketSourceResearch.com/register/?so=MOBL

-----------------------------------------

ARROW ELECTRONICS, INC. (ARW) REPORT OVERVIEW

Arrow Electronics' Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Arrow Electronics reported revenue of $7,918.18MM vs $7,539.45MM (up 5.02%) and analysts estimated basic earnings per share $2.65 vs $0.61 (up 334.43%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, Arrow Electronics reported revenue of $29,676.77MM vs $26,554.56MM (up 11.76%) and analysts estimated basic earnings per share $8.19 vs $4.54 (up 80.40%). Analysts expect earnings to be released on May 2nd, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $1.88. The estimated EPS forecast for the next fiscal year is $9.61 and is expected to report on February 6th, 2020.

To read the full Arrow Electronics, Inc. (ARW) report, download it here: http://MarketSourceResearch.com/register/?so=ARW

-----------------------------------------

ABEONA THERAPEUTICS INC. (ABEO) REPORT OVERVIEW

Abeona Therapeutics' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Abeona Therapeutics reported revenue of $1.71MM vs $0.22MM (up 680.37%) and analysts estimated basic earnings per share -$0.34 vs -$0.13. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Abeona Therapeutics reported revenue of $0.84MM vs $0.89MM (down 5.85%) and analysts estimated basic earnings per share -$0.66 vs -$0.64. Analysts expect earnings to be released on March 15th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.19. The estimated EPS forecast for the next fiscal year is -$1.47 and is expected to report on March 15th, 2019.

To read the full Abeona Therapeutics Inc. (ABEO) report, download it here: http://MarketSourceResearch.com/register/?so=ABEO

-----------------------------------------

ABOUT MARKET SOURCE RESEARCH

Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that’s ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.

REGISTERED MEMBER STATUS

Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at compliance@MarketSourceResearch.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact: Hugo Moreau, Media Department Office: +1 (704) 343-6361 E-mail: media@MarketSourceResearch.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.